LiDCO Group plc (LON:LID) had its Corporate rating reiterated by FinnCap

Analyst Ratings For LiDCO Group plc (LON:LID)

Story continues below

Today, FinnCap reiterated its Corporate rating on LiDCO Group plc (LON:LID).

There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on LiDCO Group plc (LON:LID) is Buy with a consensus target price of GBX 14 per share, a potential .

Some recent analyst ratings include

  • 8/20/2018-LiDCO Group plc (LON:LID) had its Corporate rating reiterated by FinnCap
  • 2/16/2018-LiDCO Group plc (LON:LID) had its Buy rating reiterated by N+1 Singer with a GBX 14 price target


    About LiDCO Group plc (LON:LID)
    LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company offers LiDCOplus, a computer-based platform monitor, which is used in the intensive care unit for real-time continuous display of hemodynamic parameters, such as cardiac output, oxygen delivery, and fluid-volume responsiveness; and LiDCOrapid, a cardiac output monitor for use in the operating theatre for fluid and drug management. It also provides LiDCOview, an easy-to-use graphical display of historical hemodynamic data that is used for research and education purposes; and LiDCOunity, a hemodynamic monitoring system to support clinical decision making. The company sells its products through direct sales and a network of a network of specialty critical care and anaesthesia distributors. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom.

    Recent Trading Activity for LiDCO Group plc (LON:LID)
    Shares of LiDCO Group plc closed the previous trading session at 6,00 +0,12 2,12 % with shares trading hands.

    An ad to help with our costs